Sirolimus and tacrolimus as immune prophylaxis compared to cyclosporine with or without methotrexate in patients undergoing allogeneic haematopoietic stem cell transplantation for non-malignant disorders
Article first published online: 2 OCT 2011
© 2011 John Wiley & Sons A/S
European Journal of Haematology
Volume 87, Issue 6, pages 503–509, December 2011
How to Cite
Ringdén, O., Remberger, M., Dahllöf, G., Garming-Legert, K., Karlsson, H., Svenberg, P., Uhlin, M., Uzunel, M. and Mattsson, J. (2011), Sirolimus and tacrolimus as immune prophylaxis compared to cyclosporine with or without methotrexate in patients undergoing allogeneic haematopoietic stem cell transplantation for non-malignant disorders. European Journal of Haematology, 87: 503–509. doi: 10.1111/j.1600-0609.2011.01685.x
- Issue published online: 14 NOV 2011
- Article first published online: 2 OCT 2011
- Accepted for publication 13 July 2011
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.